Rising Interest Rates And Tariffs Will Weaken US MedTech Margins

AN
AnalystLowTarget
AnalystLowTarget
Not Invested
Consensus Narrative from 6 Analysts
Published
10 Jul 25
Updated
16 Jul 25
AnalystLowTarget's Fair Value
SEK 37.32
13.1% undervalued intrinsic discount
16 Jul
SEK 32.44
Loading
1Y
-2.3%
7D
-2.9%

Author's Valuation

SEK 37.3

13.1% undervalued intrinsic discount

AnalystLowTarget Fair Value